Submission Details
| 510(k) Number | K092693 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 02, 2009 |
| Decision Date | November 25, 2009 |
| Days to Decision | 84 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K092693 is an FDA 510(k) clearance for the VIRAMED BIOTECH AG BORRELIA B31 IGG VIRASTRIPE, MODEL V-BBSGUS, a Reagent, Borrelia Serological Reagent (Class II — Special Controls, product code LSR), submitted by Viramed Biotech AG (Oceanside, US). The FDA issued a Cleared decision on November 25, 2009, 84 days after receiving the submission on September 2, 2009. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3830.
| 510(k) Number | K092693 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 02, 2009 |
| Decision Date | November 25, 2009 |
| Days to Decision | 84 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LSR — Reagent, Borrelia Serological Reagent |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3830 |